| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 12 |
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 7 |
Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
|
| Oct 16 |
NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains?
|
| Oct 9 |
Lineage Cell Therapeutics Inc (LCTX) Q2 2024 Earnings Call Highlights: Strategic Alliances and ...
|
| Oct 9 |
What Makes Lineage Cell (LCTX) a New Buy Stock
|
| Sep 25 |
OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
|
| Sep 18 |
Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
|
| Aug 13 |
Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
|
| Aug 10 |
Lineage Cell Therapeutics, Inc. (LCTX) Q2 2024 Earnings Call Transcript
|
